Same deceptive BS they've been putting out in their PRs for years.
NanoViricides is currently working on taking its two COVID-19 lead drug candidates, namely, NV-CoV-2- and NV-CoV-2-R, into human clinical trials. The Company believes that the essential preclinical work is substantially complete for taking these drugs into human evaluation.
I haven't been on this board in a long time. Is Dr. Diwan still CEO of NNVC? That means he regularly engages in negotiations with the CEO of Theracour, who is also Dr. Diwan. Dr. Diwan owns a higher percentage of Theracour than of Nanoviricides, so his economic incentive is to negotiate a good deal for Theracour.